Suppr超能文献

静脉输注去甲肾上腺素期间,去甲替林及其10-羟基代谢产物对血浆去甲肾上腺素(NA)浓度、心率和血压的影响。

Effects of nortriptyline and its 10-hydroxy metabolite on plasma noradrenaline (NA) concentrations, heart rate and blood pressure during intravenous NA infusion.

作者信息

Nordin C, Collste P, Otani K, Scheinin M

机构信息

Department of Psychiatry, Karolinska Institute, Huddinge Hospital, Sweden.

出版信息

Methods Find Exp Clin Pharmacol. 1987 Oct;9(10):691-6.

PMID:2964548
Abstract

Eight healthy subjects were randomly given placebo and equimolar doses of nortriptyline (NT) and E-10-hydroxy-NT (E-10-OH-NT). Two hours after oral intake of drug, noradrenaline (NA) was infused intravenously at three consecutive rates. Before infusion of NA, E-10-OH-NT significantly increased heart rate compared to NT (p less than 0.05) and placebo (p less than 0.01). During NA infusion, the active drugs caused non-significant tendencies to augmented increase of blood pressure and decrease of heart rate. Plasma NA concentrations increased significantly due to the infused NA but were not influenced by NT or E-10-OH-NT. This absence of drug effect may have been due to several simultaneously operating factors affecting plasma NA concentrations, e.g., modification of the rates of NA release and clearance by exogenous NA or drugs and competing elimination pathways for infused NA. After stopping the NA infusion, a non-significant tendency to a slower elimination of NA was found after both active drugs.

摘要

八名健康受试者被随机给予安慰剂以及等摩尔剂量的去甲替林(NT)和E-10-羟基去甲替林(E-10-OH-NT)。口服药物两小时后,以三种连续的速率静脉输注去甲肾上腺素(NA)。在输注NA之前,与NT相比,E-10-OH-NT显著增加心率(p小于0.05),与安慰剂相比显著增加心率(p小于0.01)。在NA输注期间,活性药物导致血压升高和心率降低的增加趋势不显著。由于输注NA,血浆NA浓度显著升高,但不受NT或E-10-OH-NT影响。这种药物效应的缺失可能是由于几个同时起作用的因素影响血浆NA浓度,例如,外源性NA或药物对NA释放和清除速率的改变以及输注NA的竞争性消除途径。停止NA输注后,两种活性药物给药后均发现NA消除较慢的趋势不显著。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验